Catalysts for $UTHR
22 tracked
Oct 28, 2026
earnings
UNITED THERAPEUTICS Corp earnings
UNITED THERAPEUTICS Corp
→
Aug 5, 2026
earnings
UNITED THERAPEUTICS Corp earnings
UNITED THERAPEUTICS Corp
→
Jul 29, 2026
earnings
UNITED THERAPEUTICS Corp earnings
UNITED THERAPEUTICS Corp
→
May 6, 2026
earnings
UNITED THERAPEUTICS Corp earnings
UNITED THERAPEUTICS Corp
→
Apr 3, 2026
approval
TYVASO (TREPROSTINIL) — FDA approval
UNITED THERAPEUTICS Corp
→
Oct 10, 2025
approval
UNITUXIN (DINUTUXIMAB) — FDA approval
UNITED THERAPEUTICS Corp
→
Mar 11, 2025
device 510k
Deka Research & Development Corp. — RemunityPRO Pump for Remodulin® (treprostinil) Injection (510k cleared)
UNITED THERAPEUTICS Corp
→
Jan 16, 2025
device 510k
Deka Research and Development Corp. — Remunity 2.0 Pump for Remodulin (treprostinil) Injection (510k cleared)
UNITED THERAPEUTICS Corp
→
May 20, 2022
approval
TYVASO (TREPROSTINIL) — FDA approval
UNITED THERAPEUTICS Corp
→
Mar 31, 2021
approval
TYVASO (TREPROSTINIL) — FDA approval
UNITED THERAPEUTICS Corp
→
Sep 29, 2020
approval
UNITUXIN (DINUTUXIMAB) — FDA approval
UNITED THERAPEUTICS Corp
→
Oct 19, 2017
approval
TYVASO (TREPROSTINIL) — FDA approval
UNITED THERAPEUTICS Corp
→
Mar 1, 2017
approval
UNITUXIN (DINUTUXIMAB) — FDA approval
UNITED THERAPEUTICS Corp
→
Jun 6, 2016
approval
TYVASO (TREPROSTINIL) — FDA approval
UNITED THERAPEUTICS Corp
→
Jun 23, 2015
approval
TYVASO (TREPROSTINIL) — FDA approval
UNITED THERAPEUTICS Corp
→
Mar 10, 2015
approval
UNITUXIN (DINUTUXIMAB) — FDA approval
UNITED THERAPEUTICS Corp
→
Aug 1, 2014
approval
TYVASO (TREPROSTINIL) — FDA approval
UNITED THERAPEUTICS Corp
→
May 20, 2014
approval
TYVASO (TREPROSTINIL) — FDA approval
UNITED THERAPEUTICS Corp
→
Apr 30, 2013
approval
TYVASO (TREPROSTINIL) — FDA approval
UNITED THERAPEUTICS Corp
→
Jan 7, 2013
approval
TYVASO (TREPROSTINIL) — FDA approval
UNITED THERAPEUTICS Corp
→
Feb 8, 2011
approval
TYVASO (TREPROSTINIL) — FDA approval
UNITED THERAPEUTICS Corp
→
Jul 30, 2009
approval
TYVASO (TREPROSTINIL) — FDA approval
UNITED THERAPEUTICS Corp
→